Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression

Measuring Active Microglia in Progressive Multiple Sclerosis

NCT02207075 ·Status: COMPLETED

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

NCT01428505 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

NCT01487096 ·Status: COMPLETED ·Phase: PHASE2

MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients with Multiple Sclerosis

NCT04806568 ·Status: RECRUITING ·Phase: NA

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis

NCT00134563 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period

NCT02587195 ·Status: COMPLETED ·Phase: PHASE3

Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue

NCT04144257 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

NCT00622700 ·Status: COMPLETED ·Phase: PHASE3

Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.

NCT02833714 ·Status: TERMINATED

Brain Functional Connectivity Changes Following Cognitive Rehabilitation in Multiple Sclerosis: an fMRI Study

NCT01628276 ·Status: COMPLETED ·Phase: NA

Multimodal Exploration of Patients With Multiple Sclerosis for an Early Detection of Subtle Progression

NCT05941975 ·Status: RECRUITING ·Phase: NA

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis

NCT00751881 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

NCT01433497 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT05147220 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

NCT06141473 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Does Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis Patients

NCT04625049 ·Status: ENROLLING_BY_INVITATION

Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis

NCT00097331 ·Status: COMPLETED ·Phase: PHASE2

Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis

NCT04056897 ·Status: COMPLETED ·Phase: PHASE2

Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714

NCT03691077 ·Status: UNKNOWN ·Phase: PHASE3

Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis

NCT01863888 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

NCT02792231 ·Status: COMPLETED ·Phase: PHASE3

Remediation of Emotional Processing Deficits in MS

NCT03373344 ·Status: COMPLETED ·Phase: NA

PET Study in Multiple Sclerosis

NCT03787446 ·Status: UNKNOWN

Screening for Cognitive Disorders in Multiple Sclerosis

NCT07030036 ·Status: NOT_YET_RECRUITING

A Specialized Diet for Multiple Sclerosis

NCT07033975 ·Status: RECRUITING ·Phase: NA